30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
PROSTATE cancer
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Andrei Fodor et al.
SPINAL CANCER
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: David J Park et al.
BREAST CANCER
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Asal Rahimi et al.
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Dosimetric and Treatment Efficiency Comparison of IRIS versus MLC Collimators in CyberKnife Radiosurgery for Brain AVMs
Bhooshan Zade, India | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
Dosimetric performance of Fixed and MLC collimators in robotic stereotactic radiosurgery for brain metastases
Anna Pederzoli, Italy | ESTRO | 2026
Optimizing Treatment Planning for Acoustic Neuromas with CyberKnife SRS: Preliminary Outcome Analysis
Federica Murtas, Italy | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.